This course has expired. View available courses.
Oncology, Screening & Prevention
Detecting Lung Cancer Early: Lung Cancer Screening in the Family Medicine Practice
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
This program has received financial support from AstraZeneca in the form of an unrestricted educational grant.
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-05-01
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
This program has received financial support from AstraZeneca in the form of an unrestricted educational grant.
Faculty
Stephanie Snow, MD, FRCPC
Stephen Lam, MD, FRCPC
Jeffrey Habert, MD, CCFP, FCFP
Christine Palmay, HBArtSci, MD, CCFP, FCFP
Deanna Telner, MD, Med, CFPC, FCFP
Learning objectives
At the end of this course, learners will be able to:
- Recognize the benefits of lung cancer screening on patient outcomes based on results of pilots and trials in and outside of Canada
- Understand Canadian expert consensus recommendations on lung cancer screening
Describe the guidance on eligibility and referrals for existing lung cancer screening programs and pilots in Canada- Outline the impact of smoking cessation on lung cancer mortality
Accreditation
#
of credits: 0.5
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician
Profession
0.5
# of credits
Learning Objectives
At the end of this course, learners will be able to:
- Recognize the benefits of lung cancer screening on patient outcomes based on results of pilots and trials in and outside of Canada
- Understand Canadian expert consensus recommendations on lung cancer screening
Describe the guidance on eligibility and referrals for existing lung cancer screening programs and pilots in Canada- Outline the impact of smoking cessation on lung cancer mortality
Mainpro+
ACCREDITATION
Oncology, Screening & Prevention
Learning Category
COVID-19
Topic
0
Price
2023-05-01
Expiry Date
CAN-eng
Region/Language
Course Description
Lung cancer is the leading cause for cancer-related deaths in Canada. There is evidence that early detection of lung cancer with low-dose computed tomography (LDCT) can reduce lung cancer mortality. The purpose of this program is to outline existing guidance on lung cancer screening with LDCT for primary care physicians in Canada. This program will also highlight the mortality benefits of diagnosing lung cancer at an early stage and discuss key strategies for patient engagement in the family medicine practice.
This program has received financial support from AstraZeneca in the form of an unrestricted educational grant.
Faculty
Stephanie Snow, MD, FRCPC
Stephen Lam, MD, FRCPC
Jeffrey Habert, MD, CCFP, FCFP
Christine Palmay, HBArtSci, MD, CCFP, FCFP
Deanna Telner, MD, Med, CFPC, FCFP
Accreditation
The program was peer-reviewed and accredited nationally by CFPC for up to 0.5 Mainpro+ credit(s).
30 min
Duration
0
Price
0.5
# of credits
